MJFF Publications

3551 - 3560 of 8808 Results

Title

Year

Year
2022
2022
2022
2022
2022
2022
2022
2022
2022
2022

Examining the Differences in Biomarkers of Neuronal and Glial Injury Between Autoimmune Neurologic Disease Patients and Healthy Controls
2022

Summary Details

OPEN

Title: Examining the Differences in Biomarkers of Neuronal and Glial Injury Between Autoimmune Neurologic Disease Patients and Healthy Controls

Author(s): Tyler L. Borko, Britney Barrera, Christopher Mizenko, Aurélie Ledreux, Ryan Kammeyer, Alanna Ritchie, Sean Selva, Stefan Sillau, Eric Engebretson, Rebecca Seale, Brooke Valdez, Jeffrey L. Bennett, Timothy R. Vollmer, Kavita Nair, Amanda L. Piquet

Journal Name: Neurology

Publisher: Ovid Technologies (Wolters Kluwer Health)

Vol: 99

Issue #: 23_Supplement_2

Start Page:

End Page:

Publication Date: 2022-12-05

Open Access(OA) Status: OPEN

License:

DOI - Digital Object Identifier: 10.1212/01.wnl.0000903096.36040.1d

Best OA location URL: https://n.neurology.org/content/neurology/99/23_Supplement_2/S8.full.pdf

Citation Count: 0
Issue Overview
2022

Summary Details

RESTRICTED

Title: Issue Overview

Author(s):

Journal Name: Continuum

Publisher: Ovid Technologies (Wolters Kluwer Health)

Vol: 28

Issue #: 5

Start Page:

End Page:

Publication Date: 2022-10-01

Open Access(OA) Status: RESTRICTED

License:

DOI - Digital Object Identifier: 10.1212/01.con.0000892540.33029.c0

Citation Count: 0
The ExTINGUISH Trial: A Phase-2B Randomized Placebo-Controlled Trial of Inebilizumab in Anti-NMDA Receptor Encephalitis
2022

Summary Details

OPEN

Title: The ExTINGUISH Trial: A Phase-2B Randomized Placebo-Controlled Trial of Inebilizumab in Anti-NMDA Receptor Encephalitis

Author(s): Ka‐Ho Wong, Gregory S. Day, Maarten J. Titulaer, James C. Torner, Merit Cudkowicz, Christopher S. Coffey, Codrin Lungu, Eric C. Klawiter, J. Singleton, Dana Mitchell, Janel Fedler, Dixie Ecklund, David Klements, Michele Costigan, Stacey Clardy

Journal Name: Neurology

Publisher: Ovid Technologies (Wolters Kluwer Health)

Vol: 99

Issue #: 23_Supplement_2

Start Page:

End Page:

Publication Date: 2022-12-05

Open Access(OA) Status: OPEN

License:

DOI - Digital Object Identifier: 10.1212/01.wnl.0000903316.50895.83

Best OA location URL: https://n.neurology.org/content/neurology/99/23_Supplement_2/S39.full.pdf

Citation Count: 3
Safety, Efficacy, And Pharmacokinetics of Argx-117 in Adults With Multifocal Motor Neuropathy: A Global, Multicenter, Placebo Controlled Phase 2 Study (Arda)
2022

Summary Details

OPEN

Title: Safety, Efficacy, And Pharmacokinetics of Argx-117 in Adults With Multifocal Motor Neuropathy: A Global, Multicenter, Placebo Controlled Phase 2 Study (Arda)

Author(s): Jeffrey Allen, Eduardo Nobile-Orazio, Stojan Perić, Hans Katzberg, Stephanie Cadour, Inge Van de Walle, Iris Van Hoomissen, Bert Jacquemyn, Olivier Van de Steen, W Ludo van der Pol

Journal Name: Neurology

Publisher: Ovid Technologies (Wolters Kluwer Health)

Vol: 99

Issue #: 23_Supplement_2

Start Page:

End Page:

Publication Date: 2022-12-05

Open Access(OA) Status: OPEN

License:

DOI - Digital Object Identifier: 10.1212/01.wnl.0000903320.23411.f9

Best OA location URL: https://n.neurology.org/content/neurology/99/23_Supplement_2/S40.full.pdf

Citation Count: 3
Understanding Correlation of Electroclinical Findings With Functional and Neuropsychiatric Outcomes in Patients with LGI1-Encephalitis
2022

Summary Details

RESTRICTED

Title: Understanding Correlation of Electroclinical Findings With Functional and Neuropsychiatric Outcomes in Patients with LGI1-Encephalitis

Author(s): Carol Swetlik, Amy Kunchok, Brittany Lapin, Yadi Li, Vineet Punia

Journal Name: Neurology

Publisher: Ovid Technologies (Wolters Kluwer Health)

Vol: 99

Issue #: 23_Supplement_2

Start Page:

End Page:

Publication Date: 2022-12-05

Open Access(OA) Status: RESTRICTED

License:

DOI - Digital Object Identifier: 10.1212/01.wnl.0000903424.19914.85

Citation Count: 0
An Observational Study on the Humoral and Cellular Immune Response to SARS-CoV-2 mRNA Vaccination in Multiple Sclerosis and Other Autoimmune Neurological Disorders Treated With Anti-CD20 Therapies
2022

Summary Details

OPEN

Title: An Observational Study on the Humoral and Cellular Immune Response to SARS-CoV-2 mRNA Vaccination in Multiple Sclerosis and Other Autoimmune Neurological Disorders Treated With Anti-CD20 Therapies

Author(s): Tyler L. Borko, Sean Selva, Ryan D. Baxter, Berenice Cabrera-Martinez, Cody Rester, Stefan Sillau, Daniel M. Pastula, Maite Sabalza, Iswariya Venkataraman, Eagappanath Thiruppathi, Jeffrey L. Bennett, Enrique Alarcón Álvarez, Robert A. Gross, Anna Shah, Ryan Kammeyer, Timothy R. Vollmer, Ross M. Kedl, John R. Corboy, Elena W.Y. Hsieh, Amanda L. Piquet

Journal Name: Neurology

Publisher: Ovid Technologies (Wolters Kluwer Health)

Vol: 99

Issue #: 23_Supplement_2

Start Page:

End Page:

Publication Date: 2022-12-05

Open Access(OA) Status: OPEN

License:

DOI - Digital Object Identifier: 10.1212/01.wnl.0000903428.98962.0a

Best OA location URL: https://n.neurology.org/content/neurology/99/23_Supplement_2/S52.full.pdf

Citation Count: 1
Quality of Life for Patients With Parkinson Disease
2022

Summary Details

OPEN

Title: Quality of Life for Patients With Parkinson Disease

Author(s): Lauren Talman

Journal Name: Neurology

Publisher: Ovid Technologies (Wolters Kluwer Health)

Vol: 98

Issue #: 22

Start Page:

End Page:

Publication Date: 2022-05-30

Open Access(OA) Status: OPEN

License:

DOI - Digital Object Identifier: 10.1212/wnl.0000000000200741

Citation Count: 3
Planning for Prevention of Parkinson Disease
2022

Summary Details

OPEN

Title: Planning for Prevention of Parkinson Disease

Author(s): Grace F. Crotty, Jessi L. Keavney, Roy N. Alcalay, Kenneth Marek, Gad A. Marshall, H. Diana Rosas, Michael A. Schwarzschild

Journal Name: Neurology

Publisher: Ovid Technologies (Wolters Kluwer Health)

Vol: 99

Issue #: 7_Supplement_1

Start Page: 1

End Page: 9

Publication Date: 2022-08-15

Open Access(OA) Status: OPEN

License: cc-by-nc-nd

DOI - Digital Object Identifier: 10.1212/wnl.0000000000200789

Best OA location URL: https://n.neurology.org/content/neurology/99/7_Supplement_1/1.full.pdf

Citation Count: 22
What Is the Role of Dopamine Transporter Imaging in Parkinson Prevention Clinical Trials?
2022

Summary Details

OPEN

Title: What Is the Role of Dopamine Transporter Imaging in Parkinson Prevention Clinical Trials?

Author(s): John Seibyl, Phillip H. Kuo

Journal Name: Neurology

Publisher: Ovid Technologies (Wolters Kluwer Health)

Vol: 99

Issue #: 7_Supplement_1

Start Page: 61

End Page: 67

Publication Date: 2022-08-15

Open Access(OA) Status: OPEN

License: cc-by-nc-nd

DOI - Digital Object Identifier: 10.1212/wnl.0000000000200786

Best OA location URL: https://n.neurology.org/content/neurology/99/7_Supplement_1/61.full.pdf

Citation Count: 18
Lifestyle Interventions for the Prevention of Parkinson Disease
2022

Summary Details

OPEN

Title: Lifestyle Interventions for the Prevention of Parkinson Disease

Author(s): Jules M. Janssen Daalen, Sabine Schootemeijer, Edo Richard, Sirwan K.L. Darweesh, Bastiaan R. Bloem

Journal Name: Neurology

Publisher: Ovid Technologies (Wolters Kluwer Health)

Vol: 99

Issue #: 7_Supplement_1

Start Page: 42

End Page: 51

Publication Date: 2022-08-15

Open Access(OA) Status: OPEN

License: cc-by-nc-nd

DOI - Digital Object Identifier: 10.1212/wnl.0000000000200787

Best OA location URL: https://n.neurology.org/content/neurology/99/7_Supplement_1/42.full.pdf

Citation Count: 44

Results Per Page

Page

Animations

MJFF Publications